Literature DB >> 8140090

Secondary structure characterization of beta-lactamase inclusion bodies.

T M Przybycien1, J P Dunn, P Valax, G Georgiou.   

Abstract

The secondary structure of proteins in E. coli inclusion bodies was investigated via Raman spectroscopy. Inclusion bodies were purified from cells expressing different forms of RTEM beta-lactamase and grown at either 37 or 42 degrees C. All of the solid phase inclusion body samples examined gave amide I band spectra that were perturbed from that of the native, purified protein in both solution and powder forms; secondary structure estimates indicated significant decreases in alpha-helix and increases in beta-sheet contents in the inclusion body samples. The structure estimates for inclusion bodies isolated from 37 degrees C cultures were similar, regardless of aggregate localization in the E. coli cytoplasmic or periplasmic spaces or beta-lactamase precursor content. Inclusion bodies obtained from 42 degrees C cells exhibited a further reduction of alpha-helix and augmentation of beta-sheet contents relative to those from 37 degrees C cultures. These results are consistent with the paradigm for inclusion body formation via the self-association of intra-cellular folding intermediates having extensive secondary structure content. Further, the overall secondary structure content of inclusion bodies is not significantly affected by subcellular compartmentalization, but may be altered at increased temperatures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8140090     DOI: 10.1093/protein/7.1.131

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  27 in total

1.  High pressure fosters protein refolding from aggregates at high concentrations.

Authors:  R J St John; J F Carpenter; T W Randolph
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Oxidative refolding of recombinant prochymosin.

Authors:  C Wei; B Tang; Y Zhang; K Yang
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Localization of functional polypeptides in bacterial inclusion bodies.

Authors:  Elena García-Fruitós; Anna Arís; Antonio Villaverde
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

Review 4.  Towards revealing the structure of bacterial inclusion bodies.

Authors:  Lei Wang
Journal:  Prion       Date:  2009-07-25       Impact factor: 3.931

5.  Conformation of P22 tailspike folding and aggregation intermediates probed by monoclonal antibodies.

Authors:  M A Speed; T Morshead; D I Wang; J King
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

6.  Lyophilization-induced reversible changes in the secondary structure of proteins.

Authors:  K Griebenow; A M Klibanov
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Recombinant production of ESAT-6 antigen in thermoinducible Escherichia coli: the role of culture scale and temperature on metabolic response, expression of chaperones, and architecture of inclusion bodies.

Authors:  Sara Restrepo-Pineda; Carlos G Bando-Campos; Norma A Valdez-Cruz; Mauricio A Trujillo-Roldán
Journal:  Cell Stress Chaperones       Date:  2019-06-04       Impact factor: 3.667

8.  Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli.

Authors:  Susan Idicula-Thomas; Petety V Balaji
Journal:  Protein Sci       Date:  2005-02-02       Impact factor: 6.725

9.  Folding and aggregation of TEM beta-lactamase: analogies with the formation of inclusion bodies in Escherichia coli.

Authors:  G Georgiou; P Valax; M Ostermeier; P M Horowitz
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

10.  Proline availability regulates proline-4-hydroxylase synthesis and substrate uptake in proline-hydroxylating recombinant Escherichia coli.

Authors:  Francesco Falcioni; Lars M Blank; Oliver Frick; Andreas Karau; Bruno Bühler; Andreas Schmid
Journal:  Appl Environ Microbiol       Date:  2013-03-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.